Robbins IM - Search Results

1

Causes of pulmonary hypertension in the elderly.

Pugh ME, Sivarajan L, Wang L, Robbins IM, Newman JH, Hemnes AR. Pugh ME, et al. Among authors: robbins im. Chest. 2014 Jul;146(1):159-166. doi: 10.1378/chest.13-1900. Chest. 2014. PMID: 24480915 Free PMC article.

2

A survey of diagnostic practices and the use of epoprostenol in patients with primary pulmonary hypertension.

Robbins IM, Christman BW, Newman JH, Matlock R, Loyd JE. Robbins IM, et al. Chest. 1998 Nov;114(5):1269-75. doi: 10.1378/chest.114.5.1269. Chest. 1998. PMID: 9824000

3

Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus.

Robbins IM, Gaine SP, Schilz R, Tapson VF, Rubin LJ, Loyd JE. Robbins IM, et al. Chest. 2000 Jan;117(1):14-8. doi: 10.1378/chest.117.1.14. Chest. 2000. PMID: 10631192

4

Pulmonary veno-occlusive disease: a case series and new observations.

Holcomb BW Jr, Loyd JE, Ely EW, Johnson J, Robbins IM. Holcomb BW Jr, et al. Among authors: robbins im. Chest. 2000 Dec;118(6):1671-9. Chest. 2000. PMID: 11115457

5

Iatrogenic paradoxical air embolism in pulmonary hypertension.

Holcomb BW, Loyd JE, Byrd BF 3rd, Wilsdorf TT, Casey-Cato T, Mason WR, Robbins IM. Holcomb BW, et al. Among authors: robbins im. Chest. 2001 May;119(5):1602-5. doi: 10.1378/chest.119.5.1602. Chest. 2001. PMID: 11348976

6

Increased levels of prostaglandin D(2) suggest macrophage activation in patients with primary pulmonary hypertension.

Robbins IM, Barst RJ, Rubin LJ, Gaine SP, Price PV, Morrow JD, Christman BW. Robbins IM, et al. Chest. 2001 Nov;120(5):1639-44. doi: 10.1378/chest.120.5.1639. Chest. 2001. PMID: 11713147

7

Outcome in 91 consecutive patients with pulmonary arterial hypertension receiving epoprostenol.

Kuhn KP, Byrne DW, Arbogast PG, Doyle TP, Loyd JE, Robbins IM. Kuhn KP, et al. Among authors: robbins im. Am J Respir Crit Care Med. 2003 Feb 15;167(4):580-6. doi: 10.1164/rccm.200204-333OC. Epub 2002 Nov 21. Am J Respir Crit Care Med. 2003. PMID: 12446266

8

Pulmonary veno-occlusive disease caused by an inherited mutation in bone morphogenetic protein receptor II.

Runo JR, Vnencak-Jones CL, Prince M, Loyd JE, Wheeler L, Robbins IM, Lane KB, Newman JH, Johnson J, Nichols WC, Phillips JA 3rd. Runo JR, et al. Among authors: robbins im. Am J Respir Crit Care Med. 2003 Mar 15;167(6):889-94. doi: 10.1164/rccm.200208-861OC. Epub 2002 Nov 21. Am J Respir Crit Care Med. 2003. PMID: 12446270

9

Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension: a 1-year follow-up study.

Sitbon O, Badesch DB, Channick RN, Frost A, Robbins IM, Simonneau G, Tapson VF, Rubin LJ. Sitbon O, et al. Among authors: robbins im. Chest. 2003 Jul;124(1):247-54. doi: 10.1378/chest.124.1.247. Chest. 2003. PMID: 12853530

10

Acute effects of sildenafil in patients with primary pulmonary hypertension receiving epoprostenol.

Kuhn KP, Wickersham NE, Robbins IM, Byrne DW. Kuhn KP, et al. Among authors: robbins im. Exp Lung Res. 2004 Mar;30(2):135-45. doi: 10.1080/01902140490266475. Exp Lung Res. 2004. PMID: 14972773

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

119 results

Search Page